Prof. Ahmet Öztürk is a seasoned medical professional and professor with a distinguished career in clinical practice, education, and leadership. He earned his professorship in 2002 at GATA Haydarpaşa Training Hospital, where he developed a strong foundation in medical teaching and patient care. Since 2016 he has been affiliated with Acıbadem Health Group, contributing his expertise to a leading private healthcare organization. He is an active member of the Turkish Hematology Association, participating in the professional community and staying current with advances in hematology. Known for a commitment to clinical excellence and medical education, Prof. Öztürk brings extensive experience and respected leadership to his field.
Education
- 2002 GATA Haydarpaşa Training Hospital / Professor
- 1997 GATA Haydarpaşa Training Hospital / Associate Professor
- 1995 Gulhane Military Medical Academy Hematology
- 1995 GATA Haydarpaşa Training Hospital / Assistant Professor
- 1992 Gulhane Military Medical Academy Internal Medicine
- 1984 Gulhane Military Medical Academy Faculty of Medicine
Experience
- 2016 Acibadem Health Group
- 2002 – 2009 GATA Haydarpaşa Training Hospital / Hematology Clinic Chief
- 1997 – 1998 Fred Hutchinson Cancer Research Center, Bone Marrow Transplant Center
- 1985 – 1987 Flight Medicine
Memberships
- Turkish Hemotology Association
Publications
- Effects of corticosteroids on hemostasis and pulmonary arterial pressure during chronic obstructive pulmonary disease exacerbation.
Respiration Kunter E,İlvan A,Özmen N,Demirer E,Öztürk A,Avşar K,Sayan Ö,Kartaloğlu Z - Result of treatment of acute myeloid leukemia and myelodysplastic syndrome with etoposide, thioguanine, cytarabine (ETC) in elderly patients.
Turk J Hematol 23;193-196,2006 A.Öztürk,A.Erikçi,Ö.Sayan. - A role for leptin in idiopathic thrombocytopenic purpura?
Platelets.17,501-502,2006. Akyol Alev, Ozturk Ahmet, Sayan Ozkan - Investigation of the efficacy of irinotecan in patients with fluorosil-resistant advanced colorectal cancer.
Clinical Sciences and Medicine O.Türken,M.Yaylacı,G.Kandemir,A.Öztürk,Ö Sayan - The efficacy of helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura the first study in Turkey.
Acta Hematologica 116,146-149,2006 O.Sayan,Erikçi A,Ozturk A - Pretreatment haemoglobin concentration is a prognostic factor in patients with early stage breast cacer.
J Int Med Res. 33; 319-328,2005 Kandemir E.G,Mayadağlı A,Türken O,Yaylacı M,Özturk A. - The seroprevelance of viral infections and their effects on immune system in Turkish Haemophilic patients.
Haemophilia 9,655-656, 2003 O.Türken,E.Solmazgül,S.Sipahi,A.Öztürk,H.Öztürkeri. - Prevalence and prognostic value of c-erbB2 expression in non small cell lung cancer.
Neoplasma 50,257-261,2003 O.Türken,E.Kunter,H.Çermik,T.Işıtmangil,M.Yaylacı,A.Öztürk. - Breast cancer in association with thyroid disorders.
Breast Cancer Reserch 5,110-113,2003. O.Türken,Y.Narin,S.Demirbaş,M:E.Önde,Ö.Sayan,E.G.Kandemir, M.Yaylacı, A.Öztürk - Evaluation of CA-125 as a prognostic marker in Non-Hodgkin’s Lymphoma.
Turkish Journal of Oncology 17:151-154,2002. O.Türken,Y.Narin,G.Kandemir,M.Yaylacı,A.Öztürk,B.Orhan - Prognostic significance of c-erb B-2 (HER 2/neu) Expression in Early Stage Breast Cancer and its relationship with other prognostic factors
Turkish Journal of Oncology 17:166-170,2002 O.Türken , Y.Kayacı , G.Kandemir , M.Yaylacı ,A.Öztürk N.Üskent
